2m 2m 2m 2m 2m 2m 2m
Ocular Therapeut (OCUL)
NASDAQ
$10.69+$0.20 (+1.90%)
Price as of Sep 11, 2026 7:56 PM EDT- $2.3BMarket Cap
- -18.11%1-Year Change
- BiotechnologyIndustry
Ocular Therapeut (OCUL)
$10.69+$0.20 (+1.90%)
OCUL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.49 | ||
Change | -$0.13 (-1.22%) | ||
Open | $10.75 | ||
High | $10.94 | ||
Low | $10.37 | ||
Previous Close | $10.62 | ||
Volume | 2,638,751 | ||
30-Day Average Volume | 2,775,694 | ||
1-Week Change | -1.41% | ||
1-Month Change | 7.48% | ||
1-Year Change | -18.11% | ||
3-Year Change | 170.36% | ||
5-Year Change | -3.50% | ||
Fundamentals | |||
Shares Outstanding | 219.6M | ||
Total Assets | $671.3M | ||
Market Cap | $2.3B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $13.5M | ||
Net Income | -$78.8M | ||
Free Cash Flow | -$70.6M | ||
EBIT | -$78.8M | ||
EBITDA | -$76.9M | ||
Net Working Capital | $595.3M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | 132 | ||
P/B | 4 | ||
P/E | -30 | ||
PEG | -2 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue